{"nct_id":"NCT01625338","title":"Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies","status":"COMPLETED","status_verified_date":"2015-10","start_date":"2012-06","start_date_type":null,"primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}